BIBLIOGRAFIA - REFERENCES

Tyndall A, Koike T: High dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease – Current status and future directions. Intern Med 41: 608-612, 2002

Tyndall A, on behalf of the European group for Blood and Marrow Transplantation (EBMT) and the European League Against Rheumatism (EULAR). Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease – Current status and future directions. ESCISIT Newsletter Vol 2: 9-10, 2002.

Frey D, Tyndall A.: Reaktive Arthritiden – was gibt es Neues ? Schweiz. Med. Forum 24: 577-580, 2002

Gratwohl A, Passweg J, Kühne T, Tyndall A, Holzgreve W, Skoda R, Marbet G,Tichelli A. Hämatopoietische Stammzelltransplantation. Schweiz. Med Forum 25: 597-606, 2002

Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, et al.. For the Autoimmune Disease Working Party of the EBMT. Hematopoietic stem cell transplantation for MS: a retrospective multicentre study. Journal of Neurology, 249 (8): 1088-1097, 2002

Tyndall A, Gratwohl A. The use of high dose immunoablative therapy withhematopoietic stem cell support therapy in the treatment of severe autoimmune diseases. Int J Hematol 76 (Suppl. 1): 218-222, 2002

Krieg MA, Cornuz J, Ruffieux C, Sandini L, Büche D, Dambacher MA, Hartl F,et al.: Ability of three bone ultrasounds to discriminate subjects with and without osteoporotic fractures among 7562 elderly women. J Bone Miner Res (in press, 2002)

Kroesen S, Widmer A, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TFN-a therapy.Rheumatology (accepted, 2002)

1.. A Pignone, Scaletti C, Matucci Cerinic M, Vazquez-Abad D, Del Papa N, Meroni PL, Generini S, Calzolari A, Rothfield N, Cagnoni M: Antiendothelial cell antibodies in systemic sclerosis: correlation with vascular involvement Clin Exp Rheumatol 572,16,1998

2.. JW Xu, Konttinen YT, Li TF, Waris V, Lassus J, Matucci Cerinic M, Sorsa T, Santavirta S: Production of PDGF in aseptic loosening of total hip eplacement. Rheumatol Int 215,17,1998

3.. F Falcini, De Simone L, Donzelli L, Matucci Cerinic M: Congenital conduction defects in children born to asymptomatic mothers with anti-SSA/SSB antibodies: report of two cases. Ann It Med Int 169,13,1998

4.. Ceponis A, Konttinen YT, Takagi M, Xu JW, Sorsa T, Matucci Cerinic M, Santavirta S, Bankl HC, Valent P: Expression of stem cell factor and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation. J Rheumatol 25,2304,1998

5.. M Matucci Cerinic, Generini S, Pignone A, Cagnoni M: From Raynaud’s phenomenon to systemic sclerosis: lack or exhaustion of adaptation ? Adv Org Biol 241,6,1998

6.. Matucci Cerinic M, Casale R, Del Rosso A, Generini S, Pignone A, Cagnoni M: Le complicanze neurologiche in corso di sclerosi sistemica. Ital J Neurosci 1998 s235, 19,1998

7.. M Matucci Cerinic, Iannone F, Carossino AM, Pignone A, Leoncini G, Generini S, Lapadula G, Cagnoni M: Dyscrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. J Rheumatol 347, 26,1999

8.. F Falcini , Lombardi A, Generini S, Pignone A,Cimaz R, Partsch G, Ermini M, M Matucci Cerinic: Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease ? Endothelium 209,6,1999

9.. R Cimaz, Matucci Cerinic M, Zulian F, Falcini F: Reflex sympathetic dystrophy in children. J Child Neurol 363,14,1999

10.. G Simonini, Matucci Cerinic M, Generini S, Zoppi M, Anichini M, Cesaretti A, Pignone A, Falcini F; Lotti T, Cagnoni M. Oxidative stress in systemic sclerosis Mol Cell Biochem 185,196,1999

11.. M Del Rosso, Fibbi G, Matucci Cerinic M: The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin Exp Rheumatol 485 ,17,1999

12.. S Knupp-Oliveira, Matucci Cerinic M: Polyneuropathy as initial manifestation of systemic sclerosis. Scand J Rheumatol 260,28,1999

13.. F Falcini, Azzari C, Gelli MG, Ermini M, Luchetti M, Gabrielli A, Calzolari A, Pignone A, Generini S, Matucci Cerinic M: Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. Clin Immunol 59 ,93,1999

14.. M Matucci Cerinic, G Fiori, S Generini, Systemic sclerosis: a clinical overview. Adv Exp Med Biol 73,455.1999

15.. A Del Rosso, Generini S, Pignone A, Matucci Cerinic M: Vasculitides in internal medicine. Clinics Dermatol 533, 171,1999

16.. Sergio Generini, Marco Matucci Cerinic: Raynaud’s phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 93,455,1999

17.. A Del Rosso, Generini S, Casale R, Zoppi M, Matucci Cerinic M: Neurogenic inflammattion and joint diseases. On line Rheumatology Archives1999

18.. E Witort Serraglini, Del Rosso M, Lotti T, Matucci Cerinic M: Endothelial injury in vasculitides Clinics Dermatol 587,171,1999

19.. M Matucci Cerinic, Pignone A, Generini S, Korn J: May fibroblasts determine the late different fate of systemic sclerosis and primary hypertrophic osteoarthropathy ? Clin Exp Rheumatol 1,18,2000

20.. F Falcini, Calzolari A, Pignone A, Ermini ME, Scaletti C, Zulian F, Generini S, Simonini G, Matucci Cerinic M: Bcl-2,p53 and c-myc expression in juvenile dermatomyositis. Clin Exp Rheumatol 643,18,2000

21.. G Simonini G,Generini S, Pignone A, Falcini F, Matucci Cerinic M: Diene conjugates and antibodies against oxidised low density lipoproteins in systemic sclerosis. Eur J Int Med 2000;11:289

22.. M Tuveri, Generini S, Matucci Cerinic M, Aloe L: Nerve growth factor a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000;356:1739

24.. A Del Rosso, Righi A, Casale R Generini S, Pignone A, Busciglio J, Pelsman A, Rothfield N, Conforti ML, Cagnoni M, Matucci Cerinic M; Anticorpi antineurone nella sclerosi sistemica. Reumatismo 2000;52:210

25.. Simonini S, Pignone A, Generini S, Falcini F, Matucci Cerinic M: Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 2000;155:1

26.. M Matucci Cerinic, Fiori G, Pignone A: La disabilità da patologia muscoloscheletrica nell’anziano: trials clinici. G Ital Geriatria e Gerontologia 2000;48:572

27.. G Simonini, Matucci Cerinic M, Cimaz R, Anichini A, Cesaretti S, Zoppi M, Falcini F: Evidence for immune activation against oxidised lipoproteins in inactive phase of juvenile chronic arthritis J Rheumatol 2001;28:198

28.. Herrick A, Matucci Cerinic M: The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis Clin Exp Rheumatol 2001;19:1

29.. R Livi, Teghini L, Generini S, Matucci Cerinic M: The loss of endothelial dependent control in systemic sclerosis. Chest 2001;119:672

30.. M Matucci Cerinic, Giacomelli R, Pignone , Cagnoni ML, Generini S, Casale R, Cipriani P, Del Rosso A, Tirassa P, Konttinen Y, Kahaleh MB, Pan-Sheng F, Paoletti M, Marchesi C, Cagnoni M, Aloe L: Nerve growth factor and neuropeptides circulating levels in systemic sclerosis Ann Rheum Dis 2001;60:487

31.. Djouadi K, Nedelec B, Tamouza R, Genin E, Ramasawmy R, Charron D, Delpech M, Laoussadi S, and the contributing EUROAS (Matucci Cerinic M): Interleukin 1 genes cluster polymorphisms in multiplex families with spondylarthropathies. Cytokines 2001;13:98

32.. G Valentini, Della Rossa A, Bombardieri S, Bencivelli W, Matucci Cerinic M and the European Scleroderma Study Group: Disease activity in systemic sclerosis. II. Identification of disease activity variables and development of preliminary criteria indexes Ann Rheum Dis 2001;60:592

33.. Generini, Matucci Cerinic M, Partsch G, Stancikova M, Pignone A, Konttinen YT, Rovensky J, Baker DJ, Schumacher HR jr: Evidence for hyaluronan production in the air pouch model in rats. Clin Exp Rheumatol 2001;19:271

34.. A Della Rossa, Valentini G, Bombardieri S, Bencivelli W, Matucci Cerinic M and the European Scleroderma Study Group: European multicentre study for defining the disease activity criteria of systemic sclerosis . A descriptive analysis of 318 european scleroderma patients. Ann Rheum Dis 2001; 60:585

35.. A Del Rosso , Pignone A, Giacomelli R, Matucci Cerinic M: Familial scleroderma: Do environmental factors, genes and microchimerism share the same relevance ? J Eur Acad Dermatol 2001;15:11

36.. A Pignone, Generini S, Matucci Cerinic M: PGE1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis. Clin Exp Rheumatol 2001;19:358

37.. O Kowal-Bielecka, Distler O, Neidhart M, Künzler P, Rethage J, Nawrath M, Carossino A, Pap T, Muller Ladner U, Michel BA, Sierakowski S, Matucci-Cerinic M, Gay R, Gay S: Evidence for 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis. A new pathway to skin inflammation Arthritis Reum 2001;44:1865

38.. R Giacomelli, Cipriani P, Fulminis A, Barattelli G, Matucci Cerinic M, D’Alò S, Cifone G, Tonietti G: Circulating g/d T lymphocytes of systemic sclerosis patients dysplay a T helper Th1 polarization. Clin Exp Immunol 2001;125,310

39.. P Sambo, Amico D, Giacomelli R, Matucci Cerinic M, Salsano F, Valentini G, Gabrielli A: Intravenous N-acetylcysteine for the treatment of Raynaud’s phenomenon secondary to systemic sclerosis: A pilot study J Rheumatol 2001;28.2257

40.. O Distler, Pap T, Kowal-Bielecka O, Meyringer R, Guiducci S, Landthaler M, Scholmerich J, Michel B, Gay R, Matucci Cerinic M, Gay S, Muller-Ladner U: Overexpression of MCP-1 in systemic sclerosis: role of PDGF and effects of monocyte chemotaxis and collagen synthesis. Arthritis Rheum 2001;44:2665

41.. M Matucci Cerinic: I coxib: una nuova via terapeutica. Celecoxib. Annali Italiani di Medicina Interna. 2001;16 (suppl 3):104s-110s

42.. A Pignone, Matucci Cerinic M: Le patologie artrosiche. Pathos 2001;8 (suppl),4

43.. ML Brandi, Gennari L, Matucci Cerinic M, Becherini L, Falchetti A, Gennari C, Reginster JY: Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res 2001;3:270

44.. A Righi, Schiavon P, Jablonska S, Rondinone , Doria A , Todesco S, Matucci Cerinic M: Treatment of Scleromyxedema with intravenous immunoglobulins. Ann Rheum Dis 2002;61:59

45.. S Guiducci, Del Rosso A, Pignone A, Generini S, Matucci Cerinic M: Il fenomeno di Raynaud nella terza età. Giornale Italiano di Gerontologia Geriatria 2002;49:285

46.. R Giacomelli, G Valentini, F Salsano, Cipriani P, Sambo P, Conforti ML, Fulminis A, De Luca A, Farina G, Candela M, Generini S, De Francisci A, Tirri E, Proietti M, Bombardieri S, Gabrielli A, Matucci Cerinic M: Cyclophosphamide pulse regimen for the treatment of alveolitis in systemic sclerosis. J Rheumatol 2002;29:731

47.. S Gabbrielli, Pignone A, Matucci Cerinic M: Is bronchoalveolar lavage also an interstitial lavage ? Clin Exp Rheumatol 2002;20:441

48.. LIbba Manneschi, Del Rosso A, Pacini S, Bechi P, Matucci Cerinic M: The ultrastructure of the muscle coat of the gastric wall in a case of systemic sclerosis. Ann Rheum Dis 2002;61:754

49.. L Bertinotti, Pietrini U, Del Rosso A, Casale R, Colangelo N, Zoppi M, Matucci Cerinic M: The use of pupillometry in joint and connective tissue diseases Ann NY Acad Sci 2002; 966:446

50.. C Fatini, Gensini F, Sticchi E, Battaglini B, Angotti C, Conforti ML, Generini S, Pignone A, Abbate R, Matucci Cerinic M: High prevalence of ACE I/D and endothelial nitric oxide synthase glu298—Asp, but not of T-786—C polymorphism in systemic sclerosis. Am J Med 2002;112:540

51.. R Livi, Teghini L, Pignone A, Generini S, Matucci Cerinic M, Cagnoni M: Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. Ann Rheum Dis 2002;61:682

52.. R Giacomelli, Cipriani P, Matucci Cerinic M, Fulminis A, Barattelli G, Pingiotti E, Di Franco M, Trotta A, Perticone R, Zazzeroni F, Alesse E, Tonietti G: Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalfa production without decreasing TNFalfa mRNA levels. An in vivo and in vitro study. Clin Exp Rheumatol 2002;20:365

53. O Distler, del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay R, Michel BA, Brühlmann P, Müller-Ladner U, Gay S, Matucci-Cerinic M: Angiogenic and angiostatic factors in systemic sclerosis: Increased levels of vascular endothelial growth factor (VEGF) are a feature of earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002;4:r11

54.. M Matucci Cerinic, Kahaleh BM: Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatology 2002; 41:843-7.

55.. L Bertinotti, Miniati I, Matucci Cerinic M: Angioedema and systemic sclerosis. A review of the literature. Scand J Rheumatol 2002;31,178

56.. S Generini, Fiori G, Matucci Cerinic M: Therapy of spondyloarthropathy in inflammatory bowel disease. Clin Exp Rheumatol 2002;20 (suppl 28):s88

57.. G Fiori, Pignone A, Matucci Cerinic M: Overlap Syndromes. Reumatizam 2002.; 9,12

58.. A Righi, Matucci Cerinic M: The therapy of systemic sclerosis: the rheumatologic perspective. J Eur Acad Dermatol 2002, 16,431

59.. R Giacomelli, Matucci Cerinic S, Bombardieri S: The paradigm of Microchimerism in Sjogren syndrome and other autoimmune diseases. Ann Rheum Dis 2003; 61,1039

60.. Kalfin R, Righi A, Del Rosso A, Bagchi D, Das DK, Generini S, Guiducci S, Matucci Cerinic M: Activin, a grape seed derived proanthocyanidin extract, reduces oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) plasma levels in systemic sclerosis. Free Radical Res 2002; ;36:819

61.. P Failli, D’Alfonso C, Giovannelli L, Generini S, Del Rosso A, Pignone A, Stanflin N, Orsi M, Zilletti L, Matucci Cerinic M: N-acetyl cysteine reduces superoxide anion and peroxynitrite production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide 2002; 7:277

62.. A Pignone, Fiori G, Del Rosso A, Generini S, Matucci Cerinic M: The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. Autoimmunity Reviews 2002; 1: 226

63.. M Matucci Cerinic, Pignone A, & Giacomelli R: Microchimerismo e sclerosi sistemica. Convegno sulle malattie autoimmuni sistemiche, Firenze, 29 Settembre 2001

64.. A Pignone & Matucci Cerinic M: La patogenesi della Polimiosite/Dermatomiosite. Convegno sulle malattie autoimmuni sistemiche, Firenze, 29 Settembre 2001

65.. M Matucci Cerinic & Casale R: La riabilitazione della sclerosi sistemica. Congresso SIMFER/SIR sulla riabilitazione delle malattie reumatiche, Mantova, 10-14 Ottobre 2001

66.. M Matucci Cerinic: I COXIB una nuova via terapeutica: Celecoxib. 102 Congresso della Società Italiana di Medicina Interna, Roma, 23-27 Ottobre 2001

67.. M Matucci Cerinic: La patogenesi della sclerosi sistemica. Congresso della Società Italiana di Reumatologia, Padova, 20-24 Novembre 2001

68.. M Matucci Cerinic & Generini S: Spondiloartropatie e malattie infiammatorie intestinali. Congresso della Società Italiana di Reumatologia, Padova, 20-24 Novembre 2001

69.. M Matucci Cerinic: New insights in the treatment of osteoarthritis-clinical data on the efficacy profile of rofecoxib two years after the launch in Italy. International congress on Successful Aging, Catania 4-6 Dicembre 2001

70.. M Matucci Cerinic: Genetica e malattie reumatiche: passato, presente e futuro. Giornate Mediche Toscane, Firenze 1-2 Febbraio 2002

71.. M Matucci Cerinic: La visione globale del paziente artrosico: dall’ iter diagnostico alla costruzione di una strategia terapeutica. Osteoartrosi una malattia vera ?, Firenze, 20 Aprile 2002

72.. A Pignone, M Matucci Cerinic: Terapia della sclerosi sistemica: stato dell’arte. Le malattie autoimmuni oggi, L’Aquila, 10-11 Maggio 2002

73.. M Matucci Cerinic: La patogenesi della sclerosi sistemica. Ten Topics in Rheumatology, Roma, 16-18 Maggio 2002

74.. F Braschi, M Matucci Cerinic: A rational approach for the management of ulcers in systemic sclerosis. EULAR congress, Stockholm, 12-16 June 2002

75.. M Matucci Cerinic: The heart involvement in systemic sclerosis, Department of Rheumatology, University of Basel, Basel, 29.8.02

76.. M Matucci Cerinic: The muscle involvement in systemic sclerosis, Yugoslavian Congress of Rheumatology, Vrdnik, Serbia, 12.9.02

77.. M Matucci Cerinic: Overlap Syndromes, Croatian Congress of Rheumatology, Brijuni, Croatia, 18-19.10.02

78.. M Matucci Cerinic: From muscle to heart: the silent progression of systemic sclerosis. Grand Round, Harvard School of Medicine, Brigham and Woman Hospital, Bosoton, USA, 22.10.2002

79.. A Pignone, G Fiori, M Matucci Cerinic: L’interessamento muscolare nella sclerosi sistemica. Congresso SIR, Bari, 6-8.11.2002

80.. M Matucci Cerinic: The peripheral nervous system in systemic sclerosis. Piestany Research Meetings, Piestany, Slovacchia, 21,11,2002

81.. M Matucci Cerinic: Approccio terapeutico al paziente sclerodermico. Incontri Catanesi di Medicina Interna, Catania, 29.11.02